Chardan Healthcare Acquisition 2 (Chardan Healthcare Acquisition 2) Debt-to-EBITDA : -0.46 (As of Jun. 2021)

View and export this data going back to 2020. Start your Free Trial

What is Chardan Healthcare Acquisition 2 Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Chardan Healthcare Acquisition 2's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2021 was $0.50 Mil. Chardan Healthcare Acquisition 2's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2021 was $0.00 Mil. Chardan Healthcare Acquisition 2's annualized EBITDA for the quarter that ended in Jun. 2021 was $-1.09 Mil. Chardan Healthcare Acquisition 2's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2021 was -0.46.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Chardan Healthcare Acquisition 2's Debt-to-EBITDA or its related term are showing as below:

CHAQ.WS' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.62 Med: -0.62 Max: -0.19
Current: -0.19

During the past 3 years, the highest Debt-to-EBITDA Ratio of Chardan Healthcare Acquisition 2 was -0.19. The lowest was -0.62. And the median was -0.62.

CHAQ.WS's Debt-to-EBITDA is not ranked
in the Diversified Financial Services industry.
Industry Median: 4.145 vs CHAQ.WS: -0.19

Chardan Healthcare Acquisition 2 Debt-to-EBITDA Historical Data

The historical data trend for Chardan Healthcare Acquisition 2's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chardan Healthcare Acquisition 2 Debt-to-EBITDA Chart

Chardan Healthcare Acquisition 2 Annual Data

Trend

Dec18

Dec19

Dec20

Debt-to-EBITDA

N/A

-0.62

Chardan Healthcare Acquisition 2 Semi-Annual Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Debt-to-EBITDA	Get a 7-Day Free Trial			-6.10	-1.01	-2.38	-0.57	-0.46

Competitive Comparison of Chardan Healthcare Acquisition 2's Debt-to-EBITDA

For the Shell Companies subindustry, Chardan Healthcare Acquisition 2's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chardan Healthcare Acquisition 2's Debt-to-EBITDA Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Chardan Healthcare Acquisition 2's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Chardan Healthcare Acquisition 2's Debt-to-EBITDA falls into.

Chardan Healthcare Acquisition 2 Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Chardan Healthcare Acquisition 2's Debt-to-EBITDA for the fiscal year that ended in Dec. 2020 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.5	+	0)	/	-0.802
	=	-0.62

Chardan Healthcare Acquisition 2's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2021 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.5	+	0)	/	-1.086
	=	-0.46

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (Jun. 2021) EBITDA data.

Chardan Healthcare Acquisition 2 (AMEX:CHAQ.WS) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Chardan Healthcare Acquisition 2 Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Chardan Healthcare Acquisition 2's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Chardan Healthcare Acquisition 2 (Chardan Healthcare Acquisition 2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Chardan Healthcare Acquisition 2 Corp (AMEX:CHAQ.WS) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 State Street, 21st Floor, New York, NY, USA, 10004

Website

https://www.chardanhealthcarespac.com

Chardan Healthcare Acquisition 2 Corp is a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination.